Compare SCM & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCM | ACB |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.0M | 232.3M |
| IPO Year | 2012 | 2016 |
| Metric | SCM | ACB |
|---|---|---|
| Price | $7.28 | $5.23 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $10.13 | $4.24 |
| AVG Volume (30 Days) | 128.6K | ★ 1.3M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | ★ 13.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.85 | $9.38 |
| P/E Ratio | $11.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.54 | $2.56 |
| 52 Week High | $13.55 | $6.36 |
| Indicator | SCM | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 54.15 | 76.72 |
| Support Level | $6.83 | $3.78 |
| Resistance Level | $8.92 | N/A |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | 0.09 | 0.13 |
| Stochastic Oscillator | 82.42 | 93.15 |
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.